English
简体中文
Total: £ 56.28
2026-03-25 | Pages: 92 | Tables: 96
The global Sodium Iodide (131I) Diagnostic Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global...
2026-03-25 | Pages: 117 | Tables: 112
The global Sodium Iodide (131I) Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-25 | Pages: 112 | Tables: 110
The global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the ...
2026-03-25 | Pages: 97 | Tables: 90
The global Penem Drug Intermediates 4-AA market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-25 | Pages: 92 | Tables: 96
The global Penem Antibiotic Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic ...
2026-03-25 | Pages: 121 | Tables: 123
The global Cancer Immuno Personalized Medicine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Immunotherapy is a type of medical treatment that harnesses the body's own immune...
2026-03-25 | Pages: 93 | Tables: 99
The global Penem Drug Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsc...
2026-03-25 | Pages: 111 | Tables: 110
The global Cephalosporin Antibiotic Side Chain Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into t...
2026-03-25 | Pages: 124 | Tables: 132
The global Cancer Immunotherapy Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Immunotherapy is a type of medical treatment that harnesses the body's own immune system t...
2026-03-25 | Pages: 133 | Tables: 138
The global Immunosuppressants in Cancer Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Immunotherapy is a type of medical treatment that harnesses the body's own immun...
2026-03-25 | Pages: 112 | Tables: 110
The global Cephalosporin Antibiotic Core Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-03-25 | Pages: 110 | Tables: 116
The global Cephalosporin Antibiotic Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
2026-03-25 | Pages: 123 | Tables: 125
The global Oncogene Inhibitors market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-25 | Pages: 119 | Tables: 125
The global Plant-Based Gummy Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-25 | Pages: 106 | Tables: 95
The global Macrolide Antibiotic Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
